Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
ANIP
Ani Pharmaceuticals Inc. ANIP
$82.58
โ–ฒ +0.04% 24H
5.7095.62185.55275.47365.402001-072007-102014-012020-032026-06

About

ANI Pharmaceuticals Inc. is a diversified biopharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. It specializes in a range of dosage forms, including liquid, powder, oral solid-dose products, injectables, softgel capsules, semi-solids, topicals, and controllโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees970
TickerANIP

Statistics

Market Cap$1.89B
Revenue (TTM)$883.4M
Net Income$78.3M
Net Margin8.9%
EPS$3.32
P/E20.88
P/S2.01
P/B3.10
EV/EBITDA10.33
ROE18.3%
Dividend Yieldโ€”
Price$82.58

Data: Twelve Data ยท Revenue = mcap / P/S

Ani Pharmaceuticals Inc. (ANIP) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap